Business Standard

Wednesday, January 08, 2025 | 08:31 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Marksans Pharma Share Price

Know More
BSENSE

289.10 3.75 (1.31%)

04:01 PM, 7-Jan-2025

289.45 3.85 (1.35%)

03:53 PM, 7-Jan-2025

BSE : 524404

NSE : MARKSANS

Sector : Health care

ISIN Code : INE750C01026

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 07-Jan-2025 | 04:01 PM IST

Market Cap (₹ Cr)

13,102

Traded Value (₹ Cr)

0.98

Volume (Shares)

33,803

Face Value (₹)

1

52-Week High (₹)

358.50

52-Week High Date

02-Dec-2024

52-Week Low (₹)

126.05

52-Week Low Date

14-Mar-2024

All Time High (₹)

358.50

All Time High Date

02-Dec-2024

All Time Low (₹)

0.71

All Time Low Date

06-Mar-2003

Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April 1982. Pursuant to the Scheme of Amalgamation name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October 2005. The Company primarily engaged in the business of research manufacture marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna Goa and R & D center in Navi Mumbai.In 2004-05 the Company amalgamated with M/s. Marksans Pharma Limited (formerly M/s. Glenmark Laboratories Limited) pursuant to High Court order dated 19th August 2005. As provided in the approved Scheme of Am...
Read More

Marksans Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

13,118

EPS - TTM (₹) [C]

7.66

P/E Ratio (X) [C]

37.79

Face Value (₹) 1
Latest Dividend (%)60.00
Latest Dividend Date 17-Sep-2024
Dividend Yield (%) 0.21
Book Value Share (₹) [C]50.34
P/B Ratio (₹) [C]5.75

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
UTI-Small Cap Fund - Direct (IDCW) 66.01 22,25,075 1.40
UTI-Small Cap Fund - Direct (G) 66.01 22,25,075 1.40
UTI-Small Cap Fund (IDCW) 66.01 22,25,075 1.40
UTI-Small Cap Fund (G) 66.01 22,25,075 1.40
UTI-Aggressive Hybrid Fund (IDCW) 44.38 14,96,146 0.73
UTI-Aggressive Hybrid Fund - Direct (IDCW) 44.38 14,96,146 0.73
UTI-Aggressive Hybrid Fund - Direct (G) 44.38 14,96,146 0.73
UTI-Aggressive Hybrid Fund (G) 44.38 14,96,146 0.73
UTI-Large & Mid Cap Fund - Direct (G) 31.44 10,59,911 0.76
UTI-Large & Mid Cap Fund (G) 31.44 10,59,911 0.76

Load more

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

281.20

293.35

Week Low/High (₹)

281.20

308.00

Month Low/High (₹)

276.00

348.00

Year Low/High (₹)

130.00

359.00

All time Low/High (₹)

0.71

359.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.44%-2.43%0.080.27%
1 Month-14.98%-15.02%-4.30-3.93%
3 Month6.08%6.01%-3.52-4.39%
6 Month54.04%53.97%-2.25-2.53%
1 Year68.82%68.78%8.579.20%
3 Year372.96%373.73%30.8933.10%

Company Info

Company Information

Chairman & Managing Director : Mark Saldanha

Company Sec. & Compli. Officer : Harshavardhan Panigrahi

Non-Exec. & Independent Dir. : Seetharama Raju Buddharaju

Whole-time Director : Sandra Saldanha

Non-Exec. & Independent Dir. : Digant Mahesh Parikh

Whole-time Director : Varddhman Vikramaditya Jain

Non-Exec. & Independent Dir. : Abhinna Sundar Mohanty

Non Executive Director : Sunny Sharma

Independent Director : Shailaja Vardhan

Registered Office: 11th Flr GRANDEUR Oshiwara, Veera Desai Extn Rd Andheri(W),Mumbai,Maharashtra-400053 Ph: 91-22-40012000

Email:companysecretary@marksanspharma.com ; info@marksan

URL:http://www.marksanspharma.com

FAQs about Marksans Pharma Ltd

1. What's the Marksans Pharma Ltd share price today?
Marksans Pharma Ltd share price was Rs 289.10 at 04:01 PM IST on 7th Jan 2025. Marksans Pharma Ltd share price was up by 1.31% over the previous closing price of Rs 285.35. Marksans Pharma Ltd share price trend:

  • Last 1 Month: Marksans Pharma Ltd share price moved down by 14.98% on BSE
  • Last 3 Months: Marksans Pharma Ltd share price moved up by 6.08% on BSE
  • Last 12 Months: Marksans Pharma Ltd share price moved up by 68.82% on BSE
  • Last 3 Years: Marksans Pharma Ltd price moved up by 372.96% on BSE


2. How can I quickly analyse the performance of the Marksans Pharma Ltd stock?
The performance of the Marksans Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 37.79
  • Price to book value ratio is 5.75
  • Dividend yield of 0.21
  • The EPS (trailing 12 months) of the Marksans Pharma Ltd stock is Rs 7.66


3. What is the market cap of Marksans Pharma Ltd?
Marksans Pharma Ltd has a market capitalisation of Rs 13,102 crore.


4. What is Marksans Pharma Ltd's 52-week high/low share price?
The Marksans Pharma Ltd’s 52-week high share price is Rs 358.50 and 52-week low share price is Rs 126.05.


5. Is the Marksans Pharma Ltd profitable?
On a consolidated basis, Marksans Pharma Ltd reported a profit of Rs 63.20 crore on a total income of Rs 339.99 crore for the quarter ended 2024. For the year ended Sep 2024, Marksans Pharma Ltd had posted a profit of Rs 97.76 crore on a total income of Rs 652.98 crore.


6. Which are Marksans Pharma Ltd’s peers in the Health care sector?
Marksans Pharma Ltd’s top 5 peers in the Health care sector are Sai Life, Granules India, Sanofi India, Marksans Pharma, Glenmark Life, Sanofi Consumer, Blue Jet Health.


7. Who owns how much in Marksans Pharma Ltd?
Key changes to the Marksans Pharma Ltd shareholding are as follows:

  • Promoter holding in Marksans Pharma Ltd has gone up to 43.87 per cent as of Sep 2024 from 43.85 per cent as of Dec 2023.